Pharmafile Logo
Pharmafocus logo
Advanced Search

Second contraceptive recall in US for packaging errors

March 5, 2012
Manufacturing and Production American Regent, Glenmark generics, McNeil Consumer

India’s Glenmark Generics has been forced to undertake a US-wide recall of seven lots of oral contraceptive product because of …

News

Contract research news in brief

March 5, 2012
Research and Development CPR, Celeron/Ricerca, Certara, PRA, Quintiles

CPR opens first bioanalytical lab in Singapore, PRA wins an MS vaccine trial contract, plus M&A and alliance news from …

News

Pharma manufacturing news in brief

March 5, 2012
Manufacturing and Production APP Pharma, Almac, Bicon Pharma, Hikal, Penn Pharma, United Drug

Our round-up of news in the pharma manufacturing sector includes updates from APP Pharma, Bicon Pharma, Penn Pharma, Almac, Hikal …

News
matt_lowe

New digital head joins Creston Health

March 5, 2012
Business Services, Medical Communications, Sales and Marketing

Matt Lowe has been appointed head of digital by the Creston Health group of companies. In his new role Lowe …

Appointment
jlowinski

Former Bayer man becomes senior VP of Sanofi’s Asia region

March 5, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Asia, Bayer, Sanofi

Sanofi has appointed Jean-Luc Lowinski as its new senior vice president of the Asia region, effective from 1 May.  Jean-Luc …

Appointment
RoActemra image

Roche’s RoActemra beats Humira in arthritis study

March 5, 2012
Research and Development, Sales and Marketing Humira, RA, RoActemra, Roche, arthritis

Roche’s rheumatoid arthritis drug RoActemra has beaten Abbott’s Humira in a head-to-head study. The Phase IV trial showed that RoActemra …

News

Catalent Completes Acquisition of Clinical Trials Supplies Business of Aptuit LLC

March 2, 2012
Research and Development

Catalent becomes #2 global clinical trial supply solutions provider

News
Press release

Chiltern welcomes Krista Stephenson to the global resourcing solutions team

March 2, 2012
Research and Development

 London, UK, February 28, 2012: Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Krista Stephenson has …

Appointment

inVentiv Health launches Super Agency

March 2, 2012
Medical Communications PR, iHCE, inVentiv, inVentiv Health Communications/Europe

inVentiv Health Communications/Europe (iHCE) has opened new headquarters in London which will serve as a hub for all European operations …

News

inVentiv Health hires Tom Sebok to lead companies within advertising group

March 2, 2012
Medical Communications, Sales and Marketing GSW, Ignite, Tom Sebok, inVentic Health

inVentiv Health has announced that Tom Sebok will be leading the company’s advertising segment as the new president of inVentiv …

Appointment

Mini-labs to fight counterfeit drugs in Africa

March 2, 2012
Sales and Marketing Africa, Merck KGaA, Zambia, counterfeits

Merck KGaA is donating equipment which can detect counterfeit drugs, while also increasing its commitment to eradicating schistosomiasis in Africa. …

News

Good Pharmacovigilance Practice modules released by European Medicine Agency

March 1, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV

The European Medicines Agency has now released drafts of the first seven Good Pharmacovigilance Practice (GPvP) Modules for public consultation.  …

News
Press release

Pharma’s international code of conduct extended

March 1, 2012
Medical Communications, Sales and Marketing Code of Practice, IFPMA, code of conduct

Pharma companies must adhere to a new stronger code of practice, no matter where they are in the world. The …

News
Lilly scientists

Academic alliances to speed Lilly’s R&D

March 1, 2012
Research and Development, Sales and Marketing R&D, academia, break through drugs, collaboration, lilly

Lilly has unveiled a range of collaborations with academic researchers which it says will help it discover and develop more …

News

AstraZeneca announces several non-executive moves

March 1, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, appointments

AstraZeneca has announced that Leif Johansson is set to be elected as a non-executive director in April, with the intention …

Appointment

Novartis appoints Brian McNamara to division head of OTC business

March 1, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brian McNamara, Novartis, OTC

Novartis has appointed Brian McNamara to the position of division head of its OTC (Over-the-Counter) business with immediate effect. McNamara …

Appointment
Rare Disease Day

‘Rare Disease Day’ highlights need for research

February 29, 2012
Research and Development, Sales and Marketing Genzyme, Rare Disease Day, Shire

 Today has been designated as Rare Disease Day around the world, with researchers, regulators and the industry all raising awareness …

News

A wake-up call for big pharma

February 29, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, McKinsey, business models, pharma

The good old days of the pharmaceutical industry are gone forever. Even an improved global economic climate is unlikely to …

Feature
Abbott image

Abbott buys into Galapagos’ RA candidate

February 29, 2012
Research and Development, Sales and Marketing Abbott, Galapagos, Humira, JAK, RA, TNF

Abbott has struck a deal with Galapagos to develop and commercialise a promising oral JAK1 inhibitor to treat multiple autoimmune …

News
Shire image

Shire signs antibody research deal with arGEN-X

February 29, 2012
Research and Development Shire, arGEN-X, monoclonal antibodies

Shire has signed a deal with antibody specialists arGEN-X to develop drugs for rare genetic diseases.Rotterdam-based arGEN-X will use its …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026